Vesugen: Vascular & Cardiovascular Bioregulator Research

Tripeptide bioregulator for blood vessel and endothelial health

Source: https://indexalabs.com/blog/vesugen-bioregulator-vascular-cardiovascular-research Abstract: Vesugen (Lys-Glu-Asp) is a synthetic tripeptide bioregulator targeting vascular endothelium and blood vessel tissue. Research focuses on its potential for cardiovascular health, endothelial function, and vascular aging.

1. Overview & Background

1.1 What is Vesugen? Vesugen is a tripeptide (Lys-Glu-Asp) bioregulator designed to support vascular endothelium and blood vessel health.

1.2 Target Tissue Primary: Vascular endothelial cells Secondary: Smooth muscle cells and broader cardiovascular tissue

1.3 Vascular Aging Endothelial dysfunction is a hallmark of cardiovascular aging, contributing to atherosclerosis, hypertension, and reduced tissue perfusion.

2. Mechanisms of Action

2.1 Endothelial Support Research suggests Vesugen may support endothelial cell viability and function.

2.2 Nitric Oxide Pathway Studies indicate potential effects on eNOS expression and nitric oxide bioavailability.

2.3 Vascular Tone May influence vascular smooth muscle relaxation and blood pressure regulation.

2.4 Anti-Inflammatory Effects Potential modulation of vascular inflammation and adhesion molecule expression.

3. Research Evidence

3.1 Endothelial Function Studies show improved endothelium-dependent vasodilation in aging models.

3.2 Blood Pressure Some research indicates beneficial effects on blood pressure parameters.

3.3 Atherosclerosis Models Animal studies suggest protective effects against vascular plaque formation.

3.4 Microcirculation Research demonstrates improved capillary blood flow and tissue perfusion.

4. Research Protocols

4.1 Vial Size Available in 20mg vials for research applications.

4.2 Cardiovascular Combinations Often studied with other cardioprotective agents and lifestyle interventions.

4.3 Assessment Methods Research uses flow-mediated dilation, pulse wave velocity, and biomarker panels.

4.4 Safety Monitoring Cardiovascular research requires appropriate hemodynamic monitoring.